Emerging Trends Redefining the Prebiotics For Infant Formula Market Landscape: Breakthrough Non-Opioid Therapy Gains FDA Approval For Safer Acute Pain Relief
We’ve updated all our reports with current data on tariff changes, trade developments, and supply chain shifts affecting key industries.
What Are the Projected Market Size and Growth Rates for the Prescription Pain Medication Market From 2025 To 2029?
In recent times, the market size for prescription pain medication has seen significant growth. Predictions indicate a rise from $73.59 billion in 2024 to $77.97 billion in 2025, with a compound annual growth rate (CAGR) of 5.9%. Factors attributing to this growth in the historic period includes a heightened incidence of chronic pain, an increase in surgical procedures, a refined focus on palliatives care, and a spike in the occurrence of musculoskeletal disorders.
The market size of prescription pain medications is predicted to experience significant expansion in the coming years, growing to $97.23 billion by 2029, propelled by a compound annual growth rate (CAGR) of 5.7%. This growth within the predicted period can be attributed to several factors such as an expanding demand for personalized medicines, heightened focus on managing post-traumatic pain, the growing adoption of telemedicine for pain management solutions, an increasing patient population seeking non-opioid alternatives, and the increased prevalence of neuropathic pain. Upcoming trends for this period are projected to involve the development of non-opioid alternatives for pain relief, integration of digital health solutions, innovative advancements in targeted pain therapies, the development of combination pain medications, and groundbreaking innovations in non-addictive pain medications.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24385&type=smp
What Are the Core Market Drivers Propelling Growth in the Prescription Pain Medication Industry?
The surge in the cases of arthritis is anticipated to fuel the expansion of the prescription pain medication market moving ahead. Arthritis, an inflammation of one or multiple joints, results in pain, swelling, stiffness, and limited mobility. The rising number of arthritis cases can be primarily attributed to obesity, which puts extra strain on joints, notably the knees, and triggers inflammation. Prescription pain drugs play a crucial role in managing arthritis by reducing inflammation and pain, enhancing joint functionality, and boosting the overall life quality for sufferers. For example, the Office for Health Improvement and Disparities, a UK government department, reported in March 2023 that in 2022, the percentage of people aged 16 and above diagnosed with arthritis or enduring back or joint issues increased to 17.6% from 17.0% in 2021. Consequently, the escalating incidence of autoimmune diseases is propelling the growth of the prescription pain medicines market.
How Is the Prescription Pain Medication Market Segmented?
The prescription pain medication market covered in this report is segmented –
1) By Type: Prescription Non-Steroidal Anti-Inflammatory Drugs, Opioids, Anti-Epileptic Medicines, Antidepressants, Other Types
2) By Route Of Administration: Oral, Injectable, Transdermal, Other Route Of Administrations
3) By Application: Neuropathic Pain, Cancer Pain, Post-Operative Pain, Other Applications
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
Subsegments:
1) By Prescription Non-Steroidal Anti-Inflammatory Drugs: COX-2 Inhibitors, Traditional Non-Steroidal Anti-Inflammatory Drugs, Combination Non-Steroidal Anti-Inflammatory Drugs
2) By Opioids: Strong Opioids, Mild Opioids, Opioid Combination Medications
3) By Anti-Epileptic Medicines: Sodium Channel Blockers, Gamma-Aminobutyric Acid Modulators, Glutamate Inhibitors
4) By Antidepressants: Selective Serotonin Reuptake Inhibitors, Tricyclic Antidepressants, Serotonin-Norepinephrine Reuptake Inhibitors, Other Antidepressants
5) By Other Types: Muscle Relaxants, Topical Pain Medications, Corticosteroids
Request customized data on this market:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24385&type=smp
Which Regions Are Driving the Next Phase of the Prescription Pain Medication Market Growth?
North America was the largest region in the prescription pain medication market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the prescription pain medication market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Key Market Trends and Innovations Are Shaping the Future of the Prescription Pain Medication Industry?
Leading businesses in the prescription pain medication market are concentrating their efforts on the creation of alternative treatments, such as non-opioid pain relievers. This is in response to the increasing alarm over opioid dependency and with an aim to advance patient safety. Non-opioid analgesics are drugs that control pain without the addiction risk associated with opioid use. They present a safer and efficient option for sustained pain control, consequently minimizing the likelihood of addiction and overdosing. For example, in January 2025, the U.S. Food and Drug Administration (FDA) granted approval to Vertex Pharmaceuticals Incorporated, a U.S. biotech firm, for JOURNAVX. This pioneering non-opioid oral drug selectively obstructs NaV1.8 sodium channels located in peripheral nerves in order to block pain signals, excluding any engagement from the central nervous system. This provides potent relief from acute pain without the danger of addiction. The drug has demonstrated significant pain reduction in Phase 3 trials for abdominoplasty and bunionectomy with a two-dose daily program. Furthermore, it is not classified as a controlled substance, thus addressing a pressing requirement for safer acute pain management procedures.
View the full report here:
https://www.thebusinessresearchcompany.com/report/prescription-pain-medication-global-market-report
How Is the Prescription Pain Medication Market Defined and What Are Its Core Parameters?
Prescription pain medication refers to drugs that are legally prescribed by a licensed healthcare provider to help manage moderate to severe pain. These medications are stronger than over-the-counter (OTC) pain relievers and are used when pain cannot be adequately controlled with non-prescription options.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/customise?id=24385&type=smp
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model